Our Perspectives

THREAD Blog

Unlocking the Patient’s Voice – The Benefits of Patient Co-Creation in Clinical Research
Insights, Engagement Leslie Yates Insights, Engagement Leslie Yates

Unlocking the Patient’s Voice – The Benefits of Patient Co-Creation in Clinical Research

While it may seem simple and obvious, one answer to making research work better for patients is through listening to them. This goes beyond simply asking them questions and recording responses (passive listening), but engaging in mindful and intentional active listening, often aided by technology, to capture insights that can lead directly to solutions that improve how clinical studies work.

Read More
Ultra-Rare Disease and Clinical Research– Different Approaches for Unique Studies
Insights, Engagement Leslie Yates Insights, Engagement Leslie Yates

Ultra-Rare Disease and Clinical Research– Different Approaches for Unique Studies

In a previous blog, we discussed ultra-rare diseases and the unique research challenges they pose to the development of new therapies. The nature of rare and ultra-rare disease means that drug development pathways and the types of studies commonly conducted can differ from the pathways and approaches used for more common diseases.

Read More
How to Give Your Clinical Trial Participants More Control, Convenience & Comfort
Inclusivity, Engagement Leslie Yates Inclusivity, Engagement Leslie Yates

How to Give Your Clinical Trial Participants More Control, Convenience & Comfort

Some estimates indicate 80% of trials are delayed due to participant retention challenges. However, sponsors and CRO’s can curb this attrition by focusing their trials on patient comfort, convenience, and by ensuring they feel in control of their participation. Adopting a truly patient-centered study design means acknowledging that every patient comes in with differing needs surrounding these three tenets and addressing them throughout trial design and execution.

Read More
Decentralized Clinical Trials: How to Balance Technology & Humanity
Insights Leslie Yates Insights Leslie Yates

Decentralized Clinical Trials: How to Balance Technology & Humanity

Hybrid and decentralized clinical trials (DCTs) are becoming more prevalent as they can better address the constraints associated with in-person visits including: mobility, proximity to research sites and the time or cost associated with attending the clinic. Although DCTs can be more convenient than in-person trials, is there a risk of relying too much on technology at the expense of person-centered communication?

Read More